This is way out of my league.
Cross-Reactivity as a Mechanism Linking Infections to Stroke
- 1Department of Neurology, University of Greifswald, Greifswald, Germany
- 2Department of Computing, Goldsmiths, University of London, London, United Kingdom
- 3Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
- 4Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
- 5Psychologische Hochschule Berlin, Berlin, Germany
Introduction
When considered separately from other cardiovascular diseases, stroke ranks fifth among all causes of death (1) and, critically, its incidence is on the rise (2).
The etiology of stroke is multifactorial with various
environmental and genetic risk factors. Hypertension, diabetes and
insulin resistance, smoking, dyslipidemia, obesity, heavy alcohol
consumption, atrial fibrillation, and carotid stenosis are all
established and well-investigated modifiable risk factors of stroke (3–5).
Additionally, there is evidence that environmental
factors may also increase risk of stroke, including viral and bacterial
infections, such as periodontitis (6) and respiratory infections (7), and infection with Chlamydia pneumoniae (8) or Cytomegalovirus (9).
However, relatively little is known so far about the role of different
pathogens as well as the molecular basis and the mechanisms that
potentially link infections to stroke.
Here we set out to investigate whether or not infections
can induce immune responses capable of cross-reacting with human
proteins that, when altered, have been associated with stroke. Our
hypothesis was that immune responses induced by infectious agents might
cross-react with crucial stroke-related proteins, thus contributing to
the multifactorial pathogenesis of cerebrovascular disease.
To address this hypothesis, we analyzed pathogens, as
well as proteins that are known to be associated with increased risk of
ischemic and hemorrhagic stroke by searching for common peptides that
might underlie cross-reactions.
Specifically, we analyzed antigens from the following
pathogens that have been reported to have a possible influence on
stroke: the periodontal bacterium Tannerella forsythia (10), Haemophilus influenza (11), Streptococcus pneumoniae (7), Chlamydia pneumoniae (8), Influenza A viruses (12, 13), and Human Cytomegalovirus (9).
Methods
We analyzed the amino acid (aa) primary sequence of pathogen antigens (with short name and UniProt ID in parentheses):
• Surface antigen repeat/outer membrane protein (OMP; UniProtKB: A0A0F7WYE8_CHLPN) from Chlamydia pneumoniae;
• Pneumococcal vaccine antigen A (PVAA;UniProtKB: PVAA_STRR6) from Streptococcus pneumoniae;
• Surface antigen BspA (BspA; UniProtKB: O68831_TANFO) from Tannerella forsythia;
• Outer membrane antigenic lipoprotein B (LPPB; UniProtKB: LPPB_HAEIN) from Haemophilus influenzae (strain ATCC 51907);
• Hemagglutinin (HA H1N1; UniProtKB: HEMA_I34A1) from Influenza A virus (strain A/Puerto Rico/8/1934 H1N1);
• Hemagglutinin (HA H5N1; UniProtKB: HEMA_I96A0) from Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1);
• Hemagglutinin (HA H3N2; UniProtKB: HEMA_I68A6) from Influenza A virus (strain A/Northern Territory/60/1968 H3N2); and
• 65 kDa phosphoprotein (pp65; UniProtKB: PP65_HCMVM) from Human Cytomegalovirus (HCMV; strain Merlin).
The primary sequence of pathogen antigens was dissected
into partially overlapping pentapeptides with a one-residue-offset:
i.e., MFKRI, FKRIR, KRIRR, and so on. Then, each pentapeptide was
analyzed for occurrences within a library consisting of primary
sequences of human proteins involved in stroke. The human protein
library was a priori chosen from the UniProtKB Database (https://www.uniprot.org) (14) using the keyword “stroke.” We obtained an unbiased list of 74 human proteins (in)directly associated with stroke (Table S1).
Stroke-related proteins are indicated as UniProtKB entry names
throughout the present article, except when discussed in detail. The
pathogen antigens and the human proteins were searched for common
sequences using the pentapeptide as a probe unit because a pentapeptide
is an immunobiological determinant sufficient for epitope-paratope
interaction and for inducing specific immune responses (15–18).
The immunologic potential of the shared peptides was analyzed using the Immune Epitope Database (IEDB; www.iedb.org) (19).
All evaluations were based only on epitopic sequences that had been
experimentally validated as immunopositive in the human host.
Results
In a detailed overview, Table 1
shows that 49 out of the 74 human stroke-related proteins share peptide
sequences with antigens from pathogens that proved to be (in)directly
involved in stroke (6–10). It can be seen that
•
The pathogen vs. human peptide overlap is unexpectedly high when
considering that the probability for two proteins to share a
pentapeptide is 1 out of 20−5, that is, 0.0000003125 or close to zero.
• The peptide overlap varies widely, with T. forsythia BspA and Influenza A HA H3N2 being the pathogen more and less involved in the peptide sharing, respectively.
•
The high number of stroke-related proteins involved in the viral
peptide overlap precludes a detailed protein-by-protein analysis.
However, an example worth noting is the human ATP-binding cassette
sub-family C member nine (ABCC9 or SUR2) that shares peptide sequences
with all of the pathogen antigens analyzed, with the exception of the
Influenza A HA H3N2 virus. ABCC9 is a subunit of ATP-sensitive potassium
channels (KATP) that can form cardiac and smooth muscle-type KATP channels with KCNJ11 and mediates neuroprotection (22).
No comments:
Post a Comment